Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma
Nature – The prodrug gliocidin effectively kills glioblastoma cells by targeting de novo purine synthesis, improving survival in mouse models.
Nature – The prodrug gliocidin effectively kills glioblastoma cells by targeting de novo purine synthesis, improving survival in mouse models.
Nature – A levitating frog, a necrophiliac duck, taxi drivers’ brains — the Ig Nobel prizes have shined a spotlight on offbeat work. Here’s an…
They don’t merely support doctors—NPs increasingly treat patients independently, including in specialty practices and emergency rooms. When they aren’t well trained, the results can be…
CCRAN’s Early Age Onset Cancer Symposium / cancer, CCRAN, City of Hope, ctDNA, EAOC24, Early Age Onset Cancer, OncoDaily, Oncology, Orange County, Pashtoon Kasi
Learn about effective cancer of unknown primary treatments with the fewest side effects. Customized options: surgery, chemotherapy, radiation therapy, proton therapy.
Nature Communications – The integration of antibody-guided cell typing and mass spectrometry-based proteomics remains challenging. Here, the authors develop Spatial and Cell-type Proteomics…
The American Lung Association’s LUNG FORCE “State of Lung Cancer” report shows how the toll of lung cancer varies by state. Look at the rates…
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. A large, single-center analysis of pediatric patients with either acquired…
Nature Reviews Urology – Here, the authors describe the evidence concerning plant-based dietary patterns and omnivorous diets with reduced consumption of animal-based food and increased…
For men with low-volume de novo metastatic castration-sensitive prostate cancer, radiotherapy to the prostate is a standard of care option due to the significant improvement…
Nature Genetics – Genome-wide association and multitrait analyses for dilated cardiomyopathy (DCM) using 9,365 cases and 946,368 controls provide insights into the mechanisms underlying DCM…